# EDGAR Filing Document

**Accession Number:** 0001881513
**File Stem:** 0001628280-23-000653
**Filing Date:** 2023-1
**Character Count:** 9820
**Document Hash:** 42ffd28c5ad01d5977d55113027d2c13
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001628280-23-000653.hdr.sgml**: 20230106

**ACCESSION NUMBER**: 0001628280-23-000653

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20230104

**FILED AS OF DATE**: 20230106

**DATE AS OF CHANGE**: 20230106

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Lubel Bryan
- **CENTRAL INDEX KEY:** 0001881513

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-40856
- **FILM NUMBER:** 23515634

**MAIL ADDRESS:**
- **STREET 1:** C/O KORE
- **STREET 2:** 3700 MANSELL ROAD, SUITE 300
- **CITY:** ALPHARETTA
- **STATE:** GA
- **ZIP:** 30022
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** KORE Group Holdings, Inc.
- **CENTRAL INDEX KEY:** 0001855457
- **STANDARD INDUSTRIAL CLASSIFICATION:** TELEPHONE COMMUNICATIONS (NO RADIO TELEPHONE) [4813]
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 3 RAVINIA DRIVE NE
- **STREET 2:** SUITE 500
- **CITY:** ATLANTA
- **STATE:** GA
- **ZIP:** 30346
- **BUSINESS PHONE:** 877-710-5673

**MAIL ADDRESS:**
- **STREET 1:** 3 RAVINIA DRIVE NE
- **STREET 2:** SUITE 500
- **CITY:** ATLANTA
- **STATE:** GA
- **ZIP:** 30346

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** King Pubco, Inc.
- **DATE OF NAME CHANGE:** 20210406

## Ex-24

```
<pre>
KORE GROUP HOLDINGS, INC.
LIMITED POWER OF ATTORNEY FOR SECTION 13 AND SECTION 16 FILINGS
I, Bryan Lubel, do hereby make, constitute and appoint each of Jack W. Kennedy Jr., Michael Thurston and Paul Holtz, and each of them acting individually, my true and lawful attorneys for the purposes hereinafter set forth, effective as of November 8, 2021.
References in this limited power of attorney to "my Attorney" are to each of the persons named above and to the person or persons substituted hereunder pursuant to the power of substitution granted herein.
I hereby grant to my Attorney, for me and in my name, place and stead, the power:
1. To execute for and on my behalf, in my capacity as a stockholder of KORE Group Holdings, Inc., a Delaware corporation (the "Company"), Schedule 13D and Schedule 13G, and all and any amendments thereto, in accordance with Section 13 of the Securities Exchange Act of 1934 and the rules and regulations promulgated thereunder (the "Exchange Act");
2. To execute for and on my behalf, in my capacity as an officer, director or stockholder of the Company, Form ID, Form 3, Form 4, and Form 5, and all and any amendments thereto, in accordance with Section 16(a) of the Exchange  Act;
3. To do and perform any and all acts for and on my behalf that may be necessary or desirable to complete and execute any such Schedule 13D,
Schedule 13G, Form ID, Form 3, Form 4 and Form 5 or any amendment thereto, and to timely file such schedule, form or amendment thereto with the United States Securities and Exchange Commission (the "SEC") and any stock exchange or similar authority; and
4. To take any other action of any type whatsoever that, in the opinion of my Attorney, may be necessary or desirable in connection with the foregoing grant of authority, it being
understood that the documents executed by my Attorney pursuant to this limited power of attorney shall be in such form and shall contain such terms and conditions as my Attorney may approve.
I hereby grant to my Attorney full power and authority to do and to perform any and every act and thing whatsoever requisite, necessary or
proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as I might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that my Attorney shall lawfully do or cause to be done by virtue of this limited power of attorney and the rights and powers herein granted. I acknowledge and agree that neither my Attorney nor the Company is assuming any of my responsibilities to comply with the Exchange Act.
This limited power of attorney shall remain in full force and effect until I am no longer
required to file any of Schedule 13D, Schedule 13G, Form 3, Form 4 or Form 5 with respect to my holdings of, and transactions in, securities of the Company, unless earlier revoked by me in a signed writing delivered to each of my Attorneys and substitutes therefor, if any. This limited
power of attorney may be filed with the SEC as a confirming statement of the authority granted
herein.
IN WITNESS WHEREOF, I have hereunto set my hand to this instrument on the date first written above.
/s/ Bryan Lubel
</pre>
```

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Lubel Bryan<br><sub>(Last) (First) (Middle)</sub><br>3 RAVINIA DR NE, SUITE 500<br><sub>(Street)</sub><br>ATLANTA, GA 30346<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2023-01-04 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_Exec. VP., Connected Health_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>KORE Group Holdings, Inc. [ KORE ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Stock | 2023-01-04 |  | M |  | 11737 | A | 0<sup>(1)</sup> | 29908 | D |  |
| Common Stock | 2023-01-04 |  | F |  | 4914<sup>(2)</sup> | D | $1.39 | 24994 | D |  |
| Common Stock | 2023-01-04 |  | M |  | 11737 | A | 0<sup>(1)</sup> | 36731 | D |  |
| Common Stock | 2023-01-04 |  | F |  | 4914<sup>(2)</sup> | D | $1.39 | 31817 | D |  |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Restricted Stock Units<sup>(1)</sup> | <sup>(3)</sup> | 2023-01-04 |  | M |  |  | 11737 | <sup>(1)(3)</sup> | <sup>(1)</sup> | Common Stock | 11737.0 | $0 | 23474 | D |  |
| Restricted Stock Units<sup>(1)</sup> | <sup>(3)</sup> | 2023-01-04 |  | M |  |  | 11737 | <sup>(1)(3)</sup> | <sup>(1)</sup> | Common Stock | 11737.0 | $0 | 23474 | D |  |

---

### Footnotes:

(1) Each restricted stock unit ("RSU") represents a right to receive one share of the issuer's common stock.

(2) Surrender of stock upon vesting of restricted stock units to satisfy tax withholding obligations.

(3) The remaining reported RSUs will vest in two equal installments on each of January 4, 2024 and January 4, 2025.

**Signature:** Jack W. Kennedy Jr., Attorney-in-Fact for Bryan Lubel  
**Date:** 2023-01-06

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**